Tuberculin skin test versus QuantiFERON-TB gold in-tube for latent tuberculosis screening in people living with HIV in a resource-limited setting

Abstract

Objective

To compare QuantiFERON-TB Gold-in-Tube (QFT) and tuberculin skin test (TST) in the diagnosis of latent tuberculosis infection (LTBI) among people living with HIV (PLWHIV).

Methods

A cross-sectional study was carried out between 2017–2018. Tuberculin skin test and QFT were performed and their concordance was measured. The gold standard for LTBI was defined as positivity to any of the tests. A logistic regression model was carried out to predict the QFT result in patients with a negative TST.

Results

A total of 510 PLWHIV were included, with 409 (80.2%) being male. The mean age of the patients was 41.3 ± 11.8 years. The median time since HIV diagnosis was 5 years (IQR 2–10), with a median CD4⁺ count of 541 (IQR 340–757) cells/mm³. Overall, 20 patients had an isolated TST+, 22 an isolated QFT+ and 15 had both positive. Concordance between tests showed a kappa coefficient of .37. Overcrowding was the only predictor for a positive QFT after a negative TST (p = .003).

Conclusion

There was fair agreement between tests in PLWHIV. In conditions of limited access to QTF, a TST-based strategy could be considered, with sequential use of QTF in high-risk patients with a negative result, especially those who live in overcrowded conditions.

Keywords

Interferon-gamma release test tuberculin test HIV infection tuberculosis infection coinfection

Get full access to this article

View all access options for this article.

References

Pai

Behr

Dowdy

, et al. Tuberculosis. Nat Rev Dis Primers 2016; 2: 16076.

World Health Organization . Global tuberculosis report, 2021. Geneva, Switzerland: WHO. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021. (2021, accessed August 2022).

CENSIDA . Boletín de atención integral de personas que viven con VIH. Spanish: CENSIDA. https://www.gob.mx/cms/uploads/attachment/file/684194/BAI_DAI_2021_4.pdf. (2021, accessed August 2022).

DGE . Sistema integral de vigilancia epidemiológica de tuberculosis 2021. Spanish: DGE. https://tuberculosis.sinave.gob.mx/ (2021, accessed October 2022).

Garfein

Laniado-Laborin

Rodwell

, et al. Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico. Emerg Infect Dis 2010; 16(5): 757–763.

Medina-Macías

Stoesslé

Perales-Rendón

, et al. Latent tuberculosis in migrants travelling through the northeast regions of Mexico. J Clin Tuberc Other Mycobact Dis 2020; 21: 100194.

World Health Organization . WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment. Geneva, Switzerland: WHO. https://www.who.int/publications/i/item/9789240001503 (2020, accessed August 2022).

Andersen

Munk

Pollock

, et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356(9235): 1099–1104.

Carranza

Pedraza-Sanchez

de Oyarzabal-Mendez

, et al. Diagnosis for latent tuberculosis infection: new alternatives. Front Immunol 2020; 11: 2006.

10.

Menzies

Pai

Comstock

. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146(5): 340–354.

11.

Campbell

Winters

Menzies

. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis. BMJ 2020; 368: m549.

12.

Adams

Howe

Andrews

, et al. Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay. AIDS Care 2017; 29(12): 1504–1509.

13.

Naseer

Naqvi

Kampmann

. Evidence for boosting mycobacterium tuberculosis-specific IFN-γ responses at 6 weeks following tuberculin skin testing. Eur Respir J 2007; 29: 1282–1283.

14.

Kerkhoff

Gupta

Samandari

, et al. The proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: a systematic review. BMC Infect Dis 2013; 13: 307.

15.

Chandrashekar

Sahin

. A survey on feature selection methods. Comput Electr Eng 2013; 40(1): 16–28.

16.

Guyon

Elisseeff

Kaelbling

. An introduction to variable and feature selection. J Mach Learn Res 2003; 3: 1157–1182.

17.

Kursa

Rudnicki

. Feature selection with the Boruta package. J Stat Soft 2010; 36(11): 1–13.

18.

Pandya

. C5.0 algorithm to improved decision tree with feature selection and reduced error pruning. Int J Comput Appl 2015; 117(16): 18–21.

19.

Deng

. Guided random forest in the RRF package. ArXiv preprint. 2013: arXiv:1306.0237.

20.

Ripley

Venables

Ripley

. Package ‘nnet’. R package. v7 (version, 7.3.12). R studio, 2016.

21.

Kabir

Islam

Murase

. A new wrapper feature selection approach using neural network. Neurocomputing 2010; 73: 3273–3283.

22.

Kuhn

Wing

Weston

, et al. Caret: classification and regression training. R package. v6.0-90 (version, 6.0-90). R studio, 2021.

23.

Oren

Alatorre-Izaguirre

Vargas-Villarreal

, et al. Interferon gamma-based detection of latent tuberculosis infection in the border states of nuevo leon and tamaulipas, Mexico. Front Public Health 2015; 3: 220.

24.

Osorio-López

Vilar-Compte

García-Tirado

, et al. Prevalence of latent tuberculosis in patients with hematological neoplasms in a cancer referral hospital in Mexico City. BMC Infect Dis 2021; 21(1): 510.

25.

Martínez-Aguilar

Serrano

Castañeda-Delgado

, et al. Associated risk factors for latent tuberculosis infection in subjects with diabetes. Associated risk factors for latent tuberculosis infection in subjects with diabetes. Arch Med Res 2015; 46(3): 221–227.

26.

Kussen

Dalla-Costa

Rossoni

, et al. Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil. Braz J Infect Dis 2016; 20(1): 69–75.

27.

Souza

Evangelista

Trajman

. Added value of QuantiFERON TB-gold in-tube for detecting latent tuberculosis infection among persons living with HIV/AIDS. Biomed Res Int 2014; 2014: 294963.

28.

Chkhartishvili

Kempker

Dvali

, et al. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia. BMC Infect Dis 2013; 13: 513.

29.

Weinfurter

Blumberg

Goldbaum

, et al. Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups. Int J Tuberc Lung Dis 2011; 15(8): 1056–1061.

30.

Balcells

Pérez

Chanqueo

, et al. A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int J Infect Dis 2008; 12(6): 645–652.

31.

Overton

Varma

Post

. Comparison of interferon-γ release assays and the tuberculin skin test for diagnosis of tuberculosis in human immunodeficiency virus: a systematic review. Tuberc Respir Dis (Seoul) 2018; 81(1): 59–72.

32.

Oliveira

Trajman

Paniago

AMM

, et al. Frequency of indeterminate results from an interferon-gamma release assay among HIV-infected individuals. J Bras Pneumol 2017; 43(3): 215–218.

33.

Cattamanchi

Smith

Steingart

, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 2011; 56(3): 230–238.

34.

Duarte

Lönnroth

Carvalho

, et al. Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology 2018; 24(2): 115–119.

35.

CENSIDA . Guía de manejo antirretroviral de las personas con VIH - México 2021. Spanish: CENSIDA. https://www.gob.mx/censida/documentos/guia-de-manejo-antirretroviral-de-las-personas-con-vih-mexico-2021-297710?idiom=es. (2021, accessed August 2022).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.09 MB